Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated cholestasis

Simonetta Costa, Rossella Iannotta, Luca Maggio, Giovanni Barone, Francesca Serrao, Giovanni Vento

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Parenteral nutrition-associated cholestasis (PNAC) is a serious complication in preterm infants receiving prolonged parenteral nutrition. Soybean lipid emulsion (SLE) seems to have a role in its pathogenesis, whereas fish oil-based emulsion (FOLE) seems to be able to reverse cholestasis. This study aimed to evaluate the effectiveness of a FOLE in reversing PNAC. Methods: The effectiveness in reversing PNAC was evaluated in prospective cohort study of very preterm infants when compared to historical controls: twenty-six infants (27.0 ± 2.6 weeks GA; 724 ± 204 g) who developed cholestasis while receiving SLE were shifted to receive FOLE and were compared with 30 infants (27.3 ± 2.5 weeks GA 838 ± 277 g) who continued to receive SLE at diagnosis of cholestasis. Results: Time to reversal of cholestasis was the same in the two study groups (45 ± 21 vs 43 ± 32 days). Conclusions: FOLE does not seem to be superior to SLE in reversing cholestasis. Considering that definitive data on the actual efficacy of FOLE to reverse PNAC are lacking, larger randomized trials are required, mainly to asses if FOLE may have a role in PNAC prevention rather than PNAC treatment.

Original languageEnglish
Article number101
JournalItalian Journal of Pediatrics
Volume44
Issue number1
DOIs
Publication statusPublished - Aug 23 2018

Fingerprint

Fish Oils
Cholestasis
Parenteral Nutrition
Emulsions
Lipids
Soybeans
Therapeutics
Premature Infants
Equidae
Cohort Studies
Prospective Studies

Keywords

  • Fish oil-based lipid emulsion
  • Parenteral nutrition-associated cholestasis
  • Preterm infants

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated cholestasis. / Costa, Simonetta; Iannotta, Rossella; Maggio, Luca; Barone, Giovanni; Serrao, Francesca; Vento, Giovanni.

In: Italian Journal of Pediatrics, Vol. 44, No. 1, 101, 23.08.2018.

Research output: Contribution to journalArticle

Costa, Simonetta ; Iannotta, Rossella ; Maggio, Luca ; Barone, Giovanni ; Serrao, Francesca ; Vento, Giovanni. / Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated cholestasis. In: Italian Journal of Pediatrics. 2018 ; Vol. 44, No. 1.
@article{4f0cacdf600d4d7582f1f89e53ca9629,
title = "Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated cholestasis",
abstract = "Background: Parenteral nutrition-associated cholestasis (PNAC) is a serious complication in preterm infants receiving prolonged parenteral nutrition. Soybean lipid emulsion (SLE) seems to have a role in its pathogenesis, whereas fish oil-based emulsion (FOLE) seems to be able to reverse cholestasis. This study aimed to evaluate the effectiveness of a FOLE in reversing PNAC. Methods: The effectiveness in reversing PNAC was evaluated in prospective cohort study of very preterm infants when compared to historical controls: twenty-six infants (27.0 ± 2.6 weeks GA; 724 ± 204 g) who developed cholestasis while receiving SLE were shifted to receive FOLE and were compared with 30 infants (27.3 ± 2.5 weeks GA 838 ± 277 g) who continued to receive SLE at diagnosis of cholestasis. Results: Time to reversal of cholestasis was the same in the two study groups (45 ± 21 vs 43 ± 32 days). Conclusions: FOLE does not seem to be superior to SLE in reversing cholestasis. Considering that definitive data on the actual efficacy of FOLE to reverse PNAC are lacking, larger randomized trials are required, mainly to asses if FOLE may have a role in PNAC prevention rather than PNAC treatment.",
keywords = "Fish oil-based lipid emulsion, Parenteral nutrition-associated cholestasis, Preterm infants",
author = "Simonetta Costa and Rossella Iannotta and Luca Maggio and Giovanni Barone and Francesca Serrao and Giovanni Vento",
year = "2018",
month = "8",
day = "23",
doi = "10.1186/s13052-018-0539-0",
language = "English",
volume = "44",
journal = "Italian Journal of Pediatrics",
issn = "1720-8424",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated cholestasis

AU - Costa, Simonetta

AU - Iannotta, Rossella

AU - Maggio, Luca

AU - Barone, Giovanni

AU - Serrao, Francesca

AU - Vento, Giovanni

PY - 2018/8/23

Y1 - 2018/8/23

N2 - Background: Parenteral nutrition-associated cholestasis (PNAC) is a serious complication in preterm infants receiving prolonged parenteral nutrition. Soybean lipid emulsion (SLE) seems to have a role in its pathogenesis, whereas fish oil-based emulsion (FOLE) seems to be able to reverse cholestasis. This study aimed to evaluate the effectiveness of a FOLE in reversing PNAC. Methods: The effectiveness in reversing PNAC was evaluated in prospective cohort study of very preterm infants when compared to historical controls: twenty-six infants (27.0 ± 2.6 weeks GA; 724 ± 204 g) who developed cholestasis while receiving SLE were shifted to receive FOLE and were compared with 30 infants (27.3 ± 2.5 weeks GA 838 ± 277 g) who continued to receive SLE at diagnosis of cholestasis. Results: Time to reversal of cholestasis was the same in the two study groups (45 ± 21 vs 43 ± 32 days). Conclusions: FOLE does not seem to be superior to SLE in reversing cholestasis. Considering that definitive data on the actual efficacy of FOLE to reverse PNAC are lacking, larger randomized trials are required, mainly to asses if FOLE may have a role in PNAC prevention rather than PNAC treatment.

AB - Background: Parenteral nutrition-associated cholestasis (PNAC) is a serious complication in preterm infants receiving prolonged parenteral nutrition. Soybean lipid emulsion (SLE) seems to have a role in its pathogenesis, whereas fish oil-based emulsion (FOLE) seems to be able to reverse cholestasis. This study aimed to evaluate the effectiveness of a FOLE in reversing PNAC. Methods: The effectiveness in reversing PNAC was evaluated in prospective cohort study of very preterm infants when compared to historical controls: twenty-six infants (27.0 ± 2.6 weeks GA; 724 ± 204 g) who developed cholestasis while receiving SLE were shifted to receive FOLE and were compared with 30 infants (27.3 ± 2.5 weeks GA 838 ± 277 g) who continued to receive SLE at diagnosis of cholestasis. Results: Time to reversal of cholestasis was the same in the two study groups (45 ± 21 vs 43 ± 32 days). Conclusions: FOLE does not seem to be superior to SLE in reversing cholestasis. Considering that definitive data on the actual efficacy of FOLE to reverse PNAC are lacking, larger randomized trials are required, mainly to asses if FOLE may have a role in PNAC prevention rather than PNAC treatment.

KW - Fish oil-based lipid emulsion

KW - Parenteral nutrition-associated cholestasis

KW - Preterm infants

UR - http://www.scopus.com/inward/record.url?scp=85052121598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052121598&partnerID=8YFLogxK

U2 - 10.1186/s13052-018-0539-0

DO - 10.1186/s13052-018-0539-0

M3 - Article

C2 - 30139361

AN - SCOPUS:85052121598

VL - 44

JO - Italian Journal of Pediatrics

JF - Italian Journal of Pediatrics

SN - 1720-8424

IS - 1

M1 - 101

ER -